Side Effects of Colchicine
The most common side effects of colchicine include gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal pain, which can be dose-dependent and may limit the ability to achieve therapeutic doses. 1, 2
Common Side Effects
Gastrointestinal Effects
- Diarrhea (occurs in approximately 17.9% of patients vs. 13.1% in control groups) 3
- Nausea and vomiting
- Abdominal pain and cramping
- Hyperperistalsis
These gastrointestinal side effects may be:
- Transient or persistent
- More common with higher doses
- Potentially reduced by splitting the daily dose
- Associated with lactose intolerance in some patients 1
Musculoskeletal Effects
- Myalgia (muscle pain) - reported in 4.2% of colchicine users 3
- Weakness
- Risk of myopathy, especially when combined with statins 4, 5
Severe Side Effects
Hematological Effects
- Blood dyscrasias (rare)
- Bone marrow depression (primarily in acute colchicine intoxication) 6
Hepatic Effects
- Elevated liver enzymes (reported in 1.9% of users) 3
- Liver dysfunction, especially with pre-existing liver disease 1
Neuromuscular Effects
Renal Effects
- Increased risk of toxicity in patients with renal impairment 4
Drug Interactions
Critical Interactions
- CYP3A4 inhibitors (clarithromycin, erythromycin, ketoconazole, protease inhibitors) can increase colchicine levels by 200-300% 4, 7
- P-glycoprotein inhibitors (cyclosporine, verapamil) increase colchicine toxicity 4, 7
- Statins (particularly simvastatin and atorvastatin) increase risk of myopathy 4
- Grapefruit juice can increase colchicine levels 2
Toxicity and Overdose
Signs of Toxicity
- Severe diarrhea and vomiting
- Muscle weakness or pain
- Unusual bleeding or bruising
- Increased infections
- Weakness or fatigue
- Pale or gray color to lips, tongue, or palms 2
Overdose Concerns
- Colchicine has a narrow therapeutic index with no clear distinction between therapeutic, toxic, and lethal doses 7
- Overdose can be fatal - the lowest reported lethal doses are 7-26 mg 7
- Acute toxicity presents in three phases:
- Gastrointestinal phase (10-24 hours)
- Multi-organ dysfunction (24 hours to 7 days)
- Recovery phase (within weeks) 7
Risk Reduction Strategies
Dosing Considerations
- Start with lower doses and increase gradually
- For FMF: 1.0-1.5 mg/day for adults is recommended 1
- For gout: Lower doses (0.5-0.6 mg three times daily) may be sufficient 1
- Consider single daily dosing to improve compliance, but divided doses may reduce side effects 1
Special Populations
- Reduce dose in patients with renal impairment 4
- Use with extreme caution in patients with severe renal or hepatic impairment 4
- Avoid in patients taking strong CYP3A4 inhibitors 4, 2
Monitoring
- Regular monitoring of complete blood counts and liver function tests 1, 4
- Monitor serum creatine kinase if muscle symptoms develop 4
- Follow up more frequently at initial diagnosis and when disease is unstable 1
Management of Side Effects
For Gastrointestinal Effects
- Temporary reduction of dairy products if lactose intolerance is suspected
- Split doses to reduce peak concentrations
- Dose reduction
- Use of antidiarrheal and spasmolytic agents
- Gradual reintroduction of the regular dose once symptoms resolve 1
For Severe Reactions
- Discontinue colchicine and seek immediate medical attention
- Consider alternative treatments such as IL-1 blockers for FMF or corticosteroids for gout 1
Colchicine remains an effective treatment for conditions like gout and FMF, but careful dosing, monitoring, and awareness of potential side effects and drug interactions are essential for safe use.